Dorian Terral

Groupama Asset Management SA (Groupama AM) is the wholly-owned asset management subsidiary of Groupama Assurances Mutuelles SA in France. Headquartered in Paris, Groupama AM was founded in 1993 and offers a range of products covering all asset classes for a variety of clients including other Groupama companies, external institutional investors, businesses and distributors. They are a socially responsible investor which integrates ESG criteria throughout their management products and processes and their commitment to stakeholders.

Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco.

Ardian SA (Ardian) is a private equity subsidiary of Ardian Holding SAS founded in 1995. The firm is headquartered in Paris, France.

Amiral Gestion SA is an independent fund management firm headquartered in Paris, France. The firm was founded by François Badelon in 2003. Amiral Gestion manages several institutional mandates and mutual funds for institutional investors, private banks, family offices and high-net worth individuals. Amiral Gestion invests in their funds alongside their clients.

ODDO BHF SE provides banking and financial services. It specializes in private banking, asset management, as well as corporate and investment banking. The company was founded in 1854 and is headquartered in Frankfurt, Germany.

Kepler Cheuvreux SA is an independent broker/dealer headquartered in Paris, France. The firm was founded by Laurent Quirin in 1997. Kepler Cheuvreux provides execution services to institutional investors. It supports equities, fixed income, derivatives, ETFS, and convertible bonds across Europe, America and Asia.

France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.

Exane Asset Management SA (Exane AM) is an alternative investment management firm headquartered in Paris, France. The firm was founded in 2001 and is a subsidiary of Exane SA, itself a subsidiary of BNP Paribas SA (EPA: BNP) in France. Exane AM manages a range of long/short equity market neutral funds designed to respond to the varied needs of a diversified European clientele, composed chiefly of institutional investors, multi-fund managers and private banking professionals.

Natixis SA (Broker) is the securities brokerage division of Natixis SA (EPA: KN), a corporate and investment bank headquartered in Paris, France. They are ultimately owned by BCPE SA. The firm provides full spectrum of broking services to various investors.

Stifel Europe Bank AG (France) (Stifel Europe Bank Paris Branch) is the French securities brokerage division of Germany-based Stifel Europe Bank AG. The firm was founded in 2012 and is ultimately owned by Stifel Financial Corp. (NYSE: SF) in the US. Headquartered in Paris, Stifel Europe Bank Paris Branch provides securities brokerage to institutional clients.

Invus SAS (Investment Management) (Invus-IM) is the investment management division of Invus SAS, a private equity firm headquartered in Paris, France. The firm is owned by The Invus Group LLC in the US. Invus-IM makes equity investments in public companies.

Aurgalys SAS provides investment research. The private company is based in Soisy sur Ecole, France. The French company was founded by Philippe Berthon. Philippe Berthon has been the CEO since incorporation.

Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France.

Part of Point72 Capital Holdings LP, Point72 France SASU is a French company that provides investment advice. The company is based in Paris, France.

Mainstay Medical Holdings Plc is a medical device company, which focuses on commercializing an innovative implantable restorative neurostimulation system, ReActiv8, for people with disabling mechanical Chronic Low Back Pain. The company was founded in 2020 and is headquartered in Dublin, Ireland.